财经首页
|
新浪首页
|
新浪导航
财经首页
美股首页
滚动
评论
经济数据
美股列表
中国概念股
美股行情中心
美股自选
(NAVB)
公司资讯
市场资讯 | 2023年06月08日 16:32
Navidea生物医药盘前涨超7% 公司昨日盘后发布Q1业绩
finviz | 2022年09月30日 20:30
Navidea Biopharmaceuticals Appoints Joshua Wilson to the Board of Directors; Announces Dates Related to its 2022 Annual Meeting of Stockholders
finviz | 2022年09月15日 20:30
Navidea Biopharmaceuticals Announces Presentation of Results from its Two Phase 2B Clinical Trials in Rheumatoid Arthritis at Upcoming American College of Rheumatology Annual Meeting
finviz | 2022年09月09日 04:00
Edited Transcript of NAVB.A earnings conference call or presentation 8-Sep-22 8:00pm GMT
finviz | 2022年09月01日 20:30
Navidea Biopharmaceuticals Announces Opening of Nine New Sites in its Pivotal Phase 3 Trial in Rheumatoid Arthritis and Termination of Binding Memorandum of Understanding with Jubilant Radiopharma
finviz | 2022年09月01日 20:00
Navidea Biopharmaceuticals Announces Oral Ruling in Case Involving Attorneys Fees
finviz | 2022年08月30日 21:30
Navidea Biopharmaceuticals Announces Closing of its Rights Offering and Second Quarter 2022 Earnings Conference Call and Business Update
finviz | 2022年08月25日 21:16
Navidea Biopharmaceuticals Announces Subscriptions of Approximately $14.2 Million from its Rights Offering
finviz | 2022年08月18日 20:26
Navidea Biopharmaceuticals Announces Extension of Subscription Period to August 24, 2022 and Updated Terms of its Previously Announced Rights Offering
finviz | 2022年08月15日 20:30
Navidea Biopharmaceuticals Reports Second Quarter 2022 Financial Results
finviz | 2022年08月04日 19:30
Navidea Biopharmaceuticals Announces Commencement of Rights Offering Subscription Period and Updated Terms of its Previously Announced Rights Offering
finviz | 2022年08月02日 04:30
Navidea Biopharmaceuticals Announces Publication of Study Examining Use of Tc99m Tilmanocept for Lymphatic Mapping and Sentinel Lymph Node Biopsy in Melanoma and Oral Cancer in Australia
finviz | 2022年08月01日 19:30
Navidea Biopharmaceuticals Reminds Investors of Todays Deadline to be a Shareholder of Record for the Previously Announced Rights Offering
finviz | 2022年07月25日 19:30
Navidea Biopharmaceuticals Announces Publication of Study Examining Tc99m Tilmanocept Imaging of Arterial Inflammation in People with HIV
finviz | 2022年07月20日 20:57
Navidea Biopharmaceuticals Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
finviz | 2022年07月05日 20:00
Navidea Biopharmaceuticals Announces Additional Bridge Loan Funding
首页  上页
下页